Additional Documents 1 – 10 of 21:
... 55 58 62 64 Chapter 4.3|Cement ............................................................................................... 67 Well Cementing Preparing for the ... Report — Chapter 4.3: Cement | 67 Chapter 4.3|Cement Figure 4.3.1. Typical completed ...
... 70.33 1.14 5.90 0.67 0.66 3.97 0.16 1.84 1.02 ... .58 0.36 0.54 0.59 3.44 3.57 3.19 −0.08 0.01 0.13 ... .32 2.62 2.53 2.39 3.23 4.67 0.94 9.34 0.35 −0 ... .26 7.55 0.12 −0.35 −1.67 −0.33 −2.22 1.13 1.15 ... .77 0.11 0.99 −0.31 −1.67 0.24 2.11 −0.04 −0.24 ...
... and claimed in the patent. (JTX14 at 3:34-43 ("Advantageously the gestogen content of ... it provides for DNG doses of 2-3 mg and 3-4 mg instead of the precise ... at least these qualifications. (Barnhart Tr. at 366-67) The Court finds that Dr. Simon has ...
Event Studies in Securities Litigation- Low Power Confounding Ef.pdf
... changes may be linked to specific information releases.”67 As a result, courts may have excessively high ... Coefficients, 35 J. CORP. L. 11, 13 (2009). 67. KLIGER & GUREVICH, supra note 1, at 32. 68 ... 5.0% -5.2% -3.6% -3.9% -4.2% -2.5% -2.8% -3.3% -4.0 -10.0 ...
... 5 of 23 PageID #: 1248 (D.I. 67, ex. 1 at ,m 6-7) ... of a co-solvent. (JTX 3, 4, 5; D.I. 67, ex. 1 at~ 15; D ... 140 Eur. J. Endocrinol. 414 (1999). (JTX 3) 5 Eberhard Nieschlag et al., Repeated ... now sold as Nebido® ("Nebido"). (D.I. 67, ex. 1 at 1J 15; D. ...
Win vs. Applied Medical Removes Risk.pdf
... for their investment decisions. Morgan Stanley Research may not 3 MORGAN STANLEY RESEARCH February 21, 2008 Covidien be distributed ... in Australia by Morgan Stanley Australia Limited A.B.N. 67 003 734 576, holder of Australian financial services licence ...
... student body promotes the “‘robust exchange of ideas,’”3 and renders classroom discussions “‘more enlightening and interesting.’” ... ,66 and this argument helped defeat the proposal.67 An even broader amendment introduced by Senator John ...
... or descriptions of the invention. Pfaff, 525 U.S. at 67-68. Merck wrote to Weider on September 25, 1998 and ... 2. Different polymorphs of a substance have different chemical properties. 3. Crystalline calcium MTHF was a desired product with known therapeutic ...
... games, enterprise applications, multi-users applications, information rendering, 3-D graphical presentation, multimedia, voice, location based ... constrained (comparing to a desktop computer)." (5:61-67) The specification explains that "the invention can be ...
Amazon v. Device Enhancement.pdf
... games, enterprise applications, multi-users applications, information rendering, 3-D graphical presentation, multimedia, voice, location based ... constrained (comparing to a desktop computer)." (5:61-67) The specification explains that "the invention can be ...